Skip to main content
OpenTrials

Clinical trial condition

Large B-cell Lymphoma

Explore clinical trials studying Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

60 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Large B-cell Lymphoma trial results

Active, Not Recruiting

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

NCT06356129

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Local Institution - 0014 Mobile, Alabama, United States
  • Local Institution - 0477 Anchorage, Alaska, United States
  • Local Institution - 0452 Phoenix, Arizona, United States
  • Local Institution - 0342 San Francisco, California, United States
View all 325 locations
View Trial Details
Active, Not Recruiting

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

NCT06047080

Conditions
Large B-cell Lymphoma
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Kaiser Permanente - Anaheim (E. La Palma) Anaheim, California, United States
  • University of California, San Francisco-Fresno Clovis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 229 locations
View Trial Details
Active, Not Recruiting

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

NCT03960840

Conditions
Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +23 more
Locations
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Uni of Chi Medi Ctr Hema and Onco Chicago, Illinois, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)

NCT05429268

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Medical University Plovdiv Plovdiv, Bulgaria
  • Acibadem Cityclinica Mhat Tokuda Sofia, Bulgaria
  • Umhat Alexandrovska Sofia Sofia, Bulgaria
  • Umhat Sv. Ivan Rilski Ead Sofia, Bulgaria
View all 61 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details

Related conditions